I think it's important to remember that this is an early stage company that has only completed a small FDA trial (equivalent to phase 1 in drug trials), which the market cap reflects. I'm not saying the share price can't increase, because it can, but IMO we are reasonably valued for a company that still needs to provide a concrete timeline to approval.
I'm here for the long haul so I have no problem being patient and I think it's very, very encouraging that we just raised $40 million essentially at the market with no options attached. That is a difficult feat for a speculative company to accomplish in these market conditions.
I think it's important to remember that this is an early stage...
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.37 |
Change
0.280(1.86%) |
Mkt cap ! $327.6M | |||
| Open | High | Low | Value | Volume |
| $15.57 | $15.84 | $15.18 | $339.6K | 22.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 328 | $15.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.46 | 256 | 1 |
View Market Depth
| Last trade - 14.51pm 21/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |